Characterization of STAT3 activation and expression in canine and human osteosarcoma
<p>Abstract</p> <p>Background</p> <p>Dysregulation of signal transducer and activator of transcription 3 (STAT3) has been implicated as a key participant in tumor cell survival, proliferation, and metastasis and is often correlated with a more malignant tumor phenotype....
Main Authors: | Li Pui-Kai, Lin Jiayuh, Bear Misty D, McCleese Jennifer K, Liao Albert T, Fossey Stacey L, Kisseberth William C, London Cheryl A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-03-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/81 |
Similar Items
-
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
by: Couto Jason I, et al.
Published: (2012-12-01) -
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
by: Li Pui-Kai, et al.
Published: (2011-03-01) -
Adoptive Natural Killer Cell Immunotherapy for Canine Osteosarcoma
by: William C. Kisseberth, et al.
Published: (2021-06-01) -
Phase I evaluation of STA-1474, a prodrug of the novel HSP90 inhibitor ganetespib, in dogs with spontaneous cancer.
by: Cheryl A London, et al.
Published: (2011-01-01) -
Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma
by: Urie Bridget K, et al.
Published: (2012-05-01)